Actively and Aggressively Advocating for the Gynecologic Oncology Subspecialty and Our Patients
As oncology professionals, we know very well how rapidly things change. Events can overtake intentions and regulations can overturn precedent. At the Society of Gynecologic Oncology (SGO), our member-led teams work to create data-driven, ethics-forward and practical policies on anything that impacts our field.
Check this space for information on political developments, technological innovations and more.
The primary responsibility of the Future of Physician Payment Reform Legislative and Regulatory Affairs Task Force is to monitor the ongoing transition from a fee-for-service system to a value-based system and ensure gynecologic oncology can deliver high-quality and cost-effective care. The task force considers forward-thinking practice models for physician payment, policies that support SGO members and address multidisciplinary practice management issues that impact the care of people with gynecologic malignancies.
The Coding and Reimbursement Task Force’s primary purpose is to represent the interest of gynecologic oncologists regarding regulatory and other issues that impact coding, billing and reimbursement. They provide expertise to the Legislative and Regulatory Committee regarding reimbursement issues, and manage proposals for new and revised current procedural (CPT) codes through its partnership with the American College of Obstetricians and Gynecologists (ACOG) and its visibility within the American Medical Association (AMA) CPT Editorial Panel-sponsored national committees.
Legislative and Regulatory Affairs
The primary responsibilities of the Legislative and Regulatory Affairs Task Force is to monitor legislative and regulatory activity at the national level and communicate information to other appropriate task forces within the Health Policy and Socio-economic Committee. This work group ensures policies enacted and implemented by government are favorable to SGO members, determines SGO’s involvement in issue-specific coalitions and supports continuation of the Ovarian Cancer Research Program at the Department of Defense.